Describe in detail a pre- clinical strategy for developing compounds that interact with the target using in vitro assays and animal models. Example: PCSK9. Also, the different types of agents being developed to manipulate pcsk9 expression should be discussed.
Describe in detail a pre- clinical strategy for developing compounds that interact with the target using in vitro assays and animal models. Example: PCSK9. Also, the different types of agents being developed to manipulate pcsk9 expression should be discussed. Welcome to one of the…